• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Novartis' Sandoz dips on debut after lower than expected valuation

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 04, 2023 at 09:52: AM
via
  • Sandoz valued at 10.3 bln francs on market debut
  • Shares dip following debut at 24 francs apiece
  • Fragile stock markets make for difficult backdrop

article source
 

<



Similar threads

cafead
Novartis brings on 8 business vets for Sandoz&#039;s new board, including 4 women
Replies
0
Views
174
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
What is Novartis without Sandoz? Vas Narasimhan is &#039;patient&#039; as new company takes...
Replies
0
Views
240
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
It&#039;s a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs...
Replies
0
Views
573
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
More drug, fewer jabs: Novartis&#039; Sandoz eyes EMA nod for high-concentration Humira copy
Replies
0
Views
193
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Novartis&#039; Sandoz founds new initiative to expand biosimilar use more globally
Replies
0
Views
161
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote